Global Contrast Media Market- Industry Analysis and Forecast (2020-2027)-by Type, Application, Administration, Indication and Region.

Global Contrast Media Market- Industry Analysis and Forecast (2020-2027)-by Type, Application, Administration, Indication and Region.

Market Scenario

Global Contrast Media Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of 4.4% during a forecast period.   Market Dynamics The Research Report gives a detailed account of the drivers and restraints in the Contrast Media market. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Technical advancements to stimulus the contrast media market An upsurge in the occurrence of long-standing diseases and complex comorbidities has led to an increase in the number of diagnostic imaging tests. These consist of ultrasound, X-rays, and advanced imaging technology like Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans. To recognize the need for treatment/ surgeries in interventional procedures and perioperative scans before surgeries are projected to fuel the usage of contrast media in imaging procedures. Contrast media are used to improve the inside images of the body formed by ultrasound, X-ray, MRI, and CT scans. It helps radiologists to distinguish between normal and abnormal tissues. These dyes don’t discolor the internal organs permanently. Instead, they are the substances that momentarily change the way imaging tools interact with the body. These dyes help to contrast the particular areas of the body from the surrounding tissue, thus refining the visibility of specific tissues, blood vessels, and organs. Image-guided help determines either cancer is malignant or benign. With the raised incidence and the upsurge in the number of cancer cases in both emerging and urban economies of the world, it is essential to offer procedures that can help patients get a diagnosis at the prior stages. Primarily, Iodine and Barium-based agents were used by radiologists and specialists, currently, gold nanoparticle and radiopharmaceuticals are using widely. Advanced techniques like gas microbubble technology in gas and MRI imaging technology will demonstrate as a necessary driver in the extensive use of contrast agents. The factors like growing investments in the contrast media market and the modifications that are made in the radiopharmaceuticals and healthcare sector are enhancing the market growth. The demand for diagnostics imaging is at an all-time high, with multiple kinds of chronic diseases growing rapidly in the globe. However, the high cost of medical imaging equipment and a shortage of skilled specialists in the industry may hamper the growth of the contrast media market. With economies undergoing medical modifications affecting the sales of contrast agents and commercial slowdowns are some factors hampering the growth of the market. Global Contrast Media Market Segment analysis Based on Type, the Iodine-based contrast media agents segment is expected to grow at a CAGR of XX% during the forecast period. Iodinated contrast media will impel the overall growth of the contrast media market. Iodinated contrast media are contrast agents that include iodine atoms used for x-ray-based imaging modalities like computed tomography (CT), even though they are also used in angiography, fluoroscopy, and venography. While the intravenous route of administration is most common, they are also managed by many other routes, containing gastrointestinal (oral, rectal), vaginal, cystourethral, intraosseous, etc. Iodine has a specific benefit as a contrast agent because the k-shell binding energy (kedge) is 33.2 keV, alike to the average energy of x-rays used in diagnostic radiography 1. When the incident x-ray energy is nearer to the K-edge of the atom it encounters, photoelectric absorption is more probable to occur. Global Contrast Media Market Regional analysis The North American region has dominated the market with US$ XX Mn. North America holds a major share in the contrast media market and is anticipated to show a similar trend over the forecast period. In the United States, the first gadolinium-based contrast agent was approved. Four agents were approved in the United States in the previous years and they have set a series trend in the industry to continue to find more effective, more precise, and safe agents. The contrast media sales are anticipated to surge in the United States in the upcoming years. Amongst the different imaging modalities, sales of contrast media for the ultrasound market may have a significant growth rate. The United States is the leading consumer market for contrast media in North America. The rise in chronic diseases, like cardiovascular and neurological diseases, is the main propelling factor for market growth in the United States. The APAC region with major countries like Japan, India, and China, will impel the contrast media market in the coming years, with a steady CAGR of XX% during the forecast period. Most of the companies see favorable business forecasts in this region owing to its healthy economic growth and rising investment prospects for radiology equipment manufacturers and providers. Quickly emerging markets like India and China will also continue to grow in the nearby future. Merges and Acquisitions • In 2019, Lantheus, a parent company of Lantheus Medical Imaging Inc., acquired Progenics pharmaceuticals, Inc. to discover and treat cancer. • In 2019, Guerbet Group, merge with IBM Watson Health. The merger helped the companies to establish artificial intelligence in medical imaging to support liver cancer diagnostics. Recent Developments • In 2019, Bayer announced that they received a US FDA approval for their product Gadavist, which is a contrast agent injection used for cardiac magnetic resonance. • In November 2019, GE Healthcare announced that they have received a US FDA approval for their contrast agent Clariscan, used for Macrocyclic MRI. The injection is used intravenously and is used for MRI in the brain, spine and related tissues. The objective of the report is to present a comprehensive analysis of the Global Contrast Media Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Contrast Media Market dynamics, structure by analysing the market segments and projects the Global Contrast Media Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Contrast Media Market make the report investor’s guide.

Scope of the Global Contrast Media Market

Global Contrast Media Market, By Type

• Intravenous contrast materials • Iodine-based contrast media agents • Others

Global Contrast Media Market, By Application

• Nephrological disorders • Oncology • Cardiovascular disorders • Others

Global Contrast Media Market, By Administration

• Injectable • Rectal • Oral

Global Contrast Media Market, By Indication

• Cardiovascular Disorders • Oncology • Gastrointestinal Disorders • Musculoskeletal Disorders • Neurological Disorders • Nephrological Disorders

Global Contrast Media Market, By Regions

• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)

Key Players operating the Global Contrast Media Market

• GE Healthcare • Bracco Imaging S.P.A. • Bayer AG • Guerbet Group • Lantheus Medical Imaging, Inc. • Daiichi Sankyo • Unijules Life Sciences • J.B. Chemicals and Pharmaceuticals Ltd. • Sanochemia • Magnus Health • Taejoon Pharm • Jodas Expoim • Nano Therapeutics Pvt. Ltd. • Kiran X-Ray • Interpharma Praha A.S. • Imax Diagnostic Imaging Limited • Yangtze River Pharmaceutical Group (YRPG) • Spago Nanomedical AB • Subhra Pharma Pvt. Ltd. • M. Biotech Limited

Table of Contents

Global Contrast Media Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Contrast Media Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Contrast Media Market Analysis and Forecast 6.1. Contrast Media Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Contrast Media Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Contrast Media Market Value Share Analysis, By Type 7.4. Contrast Media Market Size (US$ Bn) Forecast, By Type 7.5. Contrast Media Market Analysis, By Type 7.6. Contrast Media Market Attractiveness Analysis, By Type 8. Global Contrast Media Market Analysis and Forecast, By Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Contrast Media Market Value Share Analysis, By Administration 8.4. Contrast Media Market Size (US$ Bn) Forecast, By Administration 8.5. Contrast Media Market Analysis, By Administration 8.6. Contrast Media Market Attractiveness Analysis, By Administration 9. Global Contrast Media Market Analysis and Forecast, By Indication 9.1. Introduction and Definition 9.2. Key Findings 9.3. Contrast Media Market Value Share Analysis, By Indication 9.4. Contrast Media Market Size (US$ Bn) Forecast, By Indication 9.5. Contrast Media Market Analysis, By Indication 9.6. Contrast Media Market Attractiveness Analysis, By Indication 10. Global Contrast Media Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Contrast Media Market Value Share Analysis, By Application 10.4. Contrast Media Market Size (US$ Bn) Forecast, By Application 10.5. Contrast Media Market Analysis, By Application 10.6. Contrast Media Market Attractiveness Analysis, By Application 11. Global Contrast Media Market Analysis, By Region 11.1. Contrast Media Market Value Share Analysis, by Region 11.2. Contrast Media Market Size (US$ Bn) Forecast, by Region 11.3. Contrast Media Market Attractiveness Analysis, by Region 12. North America Contrast Media Market Analysis 12.1. Key Findings 12.2. North America Contrast Media Market Overview 12.3. North America Contrast Media Market Value Share Analysis, By Type 12.4. North America Contrast Media Market Forecast, By Type 12.4.1. Intravenous contrast materials 12.4.2. Iodine-based contrast media agents 12.4.3. Others 12.5. North America Contrast Media Market Value Share Analysis, By Administration 12.6. North America Contrast Media Market Forecast, By Administration 12.6.1. Injectable 12.6.2. Rectal 12.6.3. Oral 12.7. North America Contrast Media Market Value Share Analysis, By Indication 12.8. North America Contrast Media Market Forecast, By Indication 12.8.1. Cardiovascular Disorders 12.8.2. Oncology 12.8.3. Gastrointestinal Disorders 12.8.4. Musculoskeletal Disorders 12.8.5. Neurological Disorders 12.8.6. Nephrological Disorders 12.9. North America Contrast Media Market Value Share Analysis, By Application 12.10. North America Contrast Media Market Forecast, By Application 12.10.1. Nephrological disorders 12.10.2. Oncology 12.10.3. Cardiovascular disorders 12.10.4. Others 12.11. North America Contrast Media Market Value Share Analysis, by Country 12.12. North America Contrast Media Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Contrast Media Market Analysis, by Country 12.14. U.S. Contrast Media Market Forecast, By Type 12.14.1. Intravenous contrast materials 12.14.2. Iodine-based contrast media agents 12.14.3. Others 12.15. U.S. Contrast Media Market Forecast, By Administration 12.15.1. Injectable 12.15.2. Rectal 12.15.3. Oral 12.16. U.S. Contrast Media Market Forecast, By Indication 12.16.1. Cardiovascular Disorders 12.16.2. Oncology 12.16.3. Gastrointestinal Disorders 12.16.4. Musculoskeletal Disorders 12.16.5. Neurological Disorders 12.16.6. Nephrological Disorders 12.17. U.S. Contrast Media Market Forecast, By Application 12.17.1. Nephrological disorders 12.17.2. Oncology 12.17.3. Cardiovascular disorders 12.17.4. Others 12.18. Canada Contrast Media Market Forecast, By Type 12.18.1. Intravenous contrast materials 12.18.2. Iodine-based contrast media agents 12.18.3. Others 12.19. Canada Contrast Media Market Forecast, By Administration 12.19.1. Injectable 12.19.2. Rectal 12.19.3. Oral 12.20. Canada Contrast Media Market Forecast, By Indication 12.20.1. Cardiovascular Disorders 12.20.2. Oncology 12.20.3. Gastrointestinal Disorders 12.20.4. Musculoskeletal Disorders 12.20.5. Neurological Disorders 12.20.6. Nephrological Disorders 12.21. Canada Contrast Media Market Forecast, By Application 12.21.1. Nephrological disorders 12.21.2. Oncology 12.21.3. Cardiovascular disorders 12.21.4. Others 12.22. North America Contrast Media Market Attractiveness Analysis 12.22.1. By Type 12.22.2. By Administration 12.22.3. By Indication 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Contrast Media Market Analysis 13.1. Key Findings 13.2. Europe Contrast Media Market Overview 13.3. Europe Contrast Media Market Value Share Analysis, By Type 13.4. Europe Contrast Media Market Forecast, By Type 13.4.1. Intravenous contrast materials 13.4.2. Iodine-based contrast media agents 13.4.3. Others 13.5. Europe Contrast Media Market Value Share Analysis, By Administration 13.6. Europe Contrast Media Market Forecast, By Administration 13.6.1. Injectable 13.6.2. Rectal 13.6.3. Oral 13.7. Europe Contrast Media Market Value Share Analysis, By Indication 13.8. Europe Contrast Media Market Forecast, By Indication 13.8.1. Cardiovascular Disorders 13.8.2. Oncology 13.8.3. Gastrointestinal Disorders 13.8.4. Musculoskeletal Disorders 13.8.5. Neurological Disorders 13.8.6. Nephrological Disorders 13.9. Europe Contrast Media Market Value Share Analysis, By Application 13.10. Europe Contrast Media Market Forecast, By Application 13.10.1. Nephrological disorders 13.10.2. Oncology 13.10.3. Cardiovascular disorders 13.10.4. Others 13.11. Europe Contrast Media Market Value Share Analysis, by Country 13.12. Europe Contrast Media Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Contrast Media Market Analysis, by Country 13.14. Germany Contrast Media Market Forecast, By Type 13.14.1. Intravenous contrast materials 13.14.2. Iodine-based contrast media agents 13.14.3. Others 13.15. Germany Contrast Media Market Forecast, By Administration 13.15.1. Injectable 13.15.2. Rectal 13.15.3. Oral 13.16. Germany Contrast Media Market Forecast, By Indication 13.16.1. Cardiovascular Disorders 13.16.2. Oncology 13.16.3. Gastrointestinal Disorders 13.16.4. Musculoskeletal Disorders 13.16.5. Neurological Disorders 13.16.6. Nephrological Disorders 13.17. Germany Contrast Media Market Forecast, By Application 13.17.1. Nephrological disorders 13.17.2. Oncology 13.17.3. Cardiovascular disorders 13.17.4. Others 13.18. U.K. Contrast Media Market Forecast, By Type 13.18.1. Intravenous contrast materials 13.18.2. Iodine-based contrast media agents 13.18.3. Others 13.19. U.K. Contrast Media Market Forecast, By Administration 13.19.1. Injectable 13.19.2. Rectal 13.19.3. Oral 13.20. U.K. Contrast Media Market Forecast, By Indication 13.20.1. Cardiovascular Disorders 13.20.2. Oncology 13.20.3. Gastrointestinal Disorders 13.20.4. Musculoskeletal Disorders 13.20.5. Neurological Disorders 13.20.6. Nephrological Disorders 13.21. U.K. Contrast Media Market Forecast, By Application 13.21.1. Nephrological disorders 13.21.2. Oncology 13.21.3. Cardiovascular disorders 13.21.4. Others 13.22. France Contrast Media Market Forecast, By Type 13.22.1. Intravenous contrast materials 13.22.2. Iodine-based contrast media agents 13.22.3. Others 13.23. France Contrast Media Market Forecast, By Administration 13.23.1. Injectable 13.23.2. Rectal 13.23.3. Oral 13.24. France Contrast Media Market Forecast, By Indication 13.24.1. Cardiovascular Disorders 13.24.2. Oncology 13.24.3. Gastrointestinal Disorders 13.24.4. Musculoskeletal Disorders 13.24.5. Neurological Disorders 13.24.6. Nephrological Disorders 13.25. France Contrast Media Market Forecast, By Application 13.25.1. Nephrological disorders 13.25.2. Oncology 13.25.3. Cardiovascular disorders 13.25.4. Others 13.26. Italy Contrast Media Market Forecast, By Type 13.26.1. Intravenous contrast materials 13.26.2. Iodine-based contrast media agents 13.26.3. Others 13.27. Italy Contrast Media Market Forecast, By Administration 13.27.1. Injectable 13.27.2. Rectal 13.27.3. Oral 13.28. Italy Contrast Media Market Forecast, By Indication 13.28.1. Cardiovascular Disorders 13.28.2. Oncology 13.28.3. Gastrointestinal Disorders 13.28.4. Musculoskeletal Disorders 13.28.5. Neurological Disorders 13.28.6. Nephrological Disorders 13.29. Italy Contrast Media Market Forecast, By Application 13.29.1. Nephrological disorders 13.29.2. Oncology 13.29.3. Cardiovascular disorders 13.29.4. Others 13.30. Spain Contrast Media Market Forecast, By Type 13.30.1. Intravenous contrast materials 13.30.2. Iodine-based contrast media agents 13.30.3. Others 13.31. Spain Contrast Media Market Forecast, By Administration 13.31.1. Injectable 13.31.2. Rectal 13.31.3. Oral 13.32. Spain Contrast Media Market Forecast, By Indication 13.32.1. Cardiovascular Disorders 13.32.2. Oncology 13.32.3. Gastrointestinal Disorders 13.32.4. Musculoskeletal Disorders 13.32.5. Neurological Disorders 13.32.6. Nephrological Disorders 13.33. Spain Contrast Media Market Forecast, By Application 13.33.1. Nephrological disorders 13.33.2. Oncology 13.33.3. Cardiovascular disorders 13.33.4. Others 13.34. Rest of Europe Contrast Media Market Forecast, By Type 13.34.1. Intravenous contrast materials 13.34.2. Iodine-based contrast media agents 13.34.3. Others 13.35. Rest of Europe Contrast Media Market Forecast, By Administration 13.35.1. Injectable 13.35.2. Rectal 13.35.3. Oral 13.36. Rest of Europe Contrast Media Market Forecast, By Indication 13.36.1. Cardiovascular Disorders 13.36.2. Oncology 13.36.3. Gastrointestinal Disorders 13.36.4. Musculoskeletal Disorders 13.36.5. Neurological Disorders 13.36.6. Nephrological Disorders 13.37. Rest Of Europe Contrast Media Market Forecast, By Application 13.37.1. Nephrological disorders 13.37.2. Oncology 13.37.3. Cardiovascular disorders 13.37.4. Others 13.38. Europe Contrast Media Market Attractiveness Analysis 13.38.1. By Type 13.38.2. By Administration 13.38.3. By Indication 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Contrast Media Market Analysis 14.1. Key Findings 14.2. Asia Pacific Contrast Media Market Overview 14.3. Asia Pacific Contrast Media Market Value Share Analysis, By Type 14.4. Asia Pacific Contrast Media Market Forecast, By Type 14.4.1. Intravenous contrast materials 14.4.2. Iodine-based contrast media agents 14.4.3. Others 14.5. Asia Pacific Contrast Media Market Value Share Analysis, By Administration 14.6. Asia Pacific Contrast Media Market Forecast, By Administration 14.6.1. Injectable 14.6.2. Rectal 14.6.3. Oral 14.7. Asia Pacific Contrast Media Market Value Share Analysis, By Indication 14.8. Asia Pacific Contrast Media Market Forecast, By Indication 14.8.1. Cardiovascular Disorders 14.8.2. Oncology 14.8.3. Gastrointestinal Disorders 14.8.4. Musculoskeletal Disorders 14.8.5. Neurological Disorders 14.8.6. Nephrological Disorders 14.9. Asia Pacific Contrast Media Market Value Share Analysis, By Application 14.10. Asia Pacific Contrast Media Market Forecast, By Application 14.10.1. Nephrological disorders 14.10.2. Oncology 14.10.3. Cardiovascular disorders 14.10.4. Others 14.11. Asia Pacific Contrast Media Market Value Share Analysis, by Country 14.12. Asia Pacific Contrast Media Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Contrast Media Market Analysis, by Country 14.14. China Contrast Media Market Forecast, By Type 14.14.1. Intravenous contrast materials 14.14.2. Iodine-based contrast media agents 14.14.3. Others 14.15. China Contrast Media Market Forecast, By Administration 14.15.1. Injectable 14.15.2. Rectal 14.15.3. Oral 14.16. China Contrast Media Market Forecast, By Indication 14.16.1. Cardiovascular Disorders 14.16.2. Oncology 14.16.3. Gastrointestinal Disorders 14.16.4. Musculoskeletal Disorders 14.16.5. Neurological Disorders 14.16.6. Nephrological Disorders 14.17. China Contrast Media Market Forecast, By Application 14.17.1. Nephrological disorders 14.17.2. Oncology 14.17.3. Cardiovascular disorders 14.17.4. Others 14.18. India Contrast Media Market Forecast, By Type 14.18.1. Intravenous contrast materials 14.18.2. Iodine-based contrast media agents 14.18.3. Others 14.19. India Contrast Media Market Forecast, By Administration 14.19.1. Injectable 14.19.2. Rectal 14.19.3. Oral 14.20. India Contrast Media Market Forecast, By Indication 14.20.1. Cardiovascular Disorders 14.20.2. Oncology 14.20.3. Gastrointestinal Disorders 14.20.4. Musculoskeletal Disorders 14.20.5. Neurological Disorders 14.20.6. Nephrological Disorders 14.21. India Contrast Media Market Forecast, By Application 14.21.1. Nephrological disorders 14.21.2. Oncology 14.21.3. Cardiovascular disorders 14.21.4. Others 14.22. Japan Contrast Media Market Forecast, By Type 14.22.1. Intravenous contrast materials 14.22.2. Iodine-based contrast media agents 14.22.3. Others 14.23. Japan Contrast Media Market Forecast, By Administration 14.23.1. Injectable 14.23.2. Rectal 14.23.3. Oral 14.24. Japan Contrast Media Market Forecast, By Indication 14.24.1. Cardiovascular Disorders 14.24.2. Oncology 14.24.3. Gastrointestinal Disorders 14.24.4. Musculoskeletal Disorders 14.24.5. Neurological Disorders 14.24.6. Nephrological Disorders 14.25. Japan Contrast Media Market Forecast, By Application 14.25.1. Nephrological disorders 14.25.2. Oncology 14.25.3. Cardiovascular disorders 14.25.4. Others 14.26. ASEAN Contrast Media Market Forecast, By Type 14.26.1. Intravenous contrast materials 14.26.2. Iodine-based contrast media agents 14.26.3. Others 14.27. ASEAN Contrast Media Market Forecast, By Administration 14.27.1. Injectable 14.27.2. Rectal 14.27.3. Oral 14.28. ASEAN Contrast Media Market Forecast, By Indication 14.28.1. Cardiovascular Disorders 14.28.2. Oncology 14.28.3. Gastrointestinal Disorders 14.28.4. Musculoskeletal Disorders 14.28.5. Neurological Disorders 14.28.6. Nephrological Disorders 14.29. ASEAN Contrast Media Market Forecast, By Application 14.29.1. Nephrological disorders 14.29.2. Oncology 14.29.3. Cardiovascular disorders 14.29.4. Others 14.30. Rest of Asia Pacific Contrast Media Market Forecast, By Type 14.30.1. Intravenous contrast materials 14.30.2. Iodine-based contrast media agents 14.30.3. Others 14.31. Rest of Asia Pacific Contrast Media Market Forecast, By Administration 14.31.1. Injectable 14.31.2. Rectal 14.31.3. Oral 14.32. Rest of Asia Pacific Contrast Media Market Forecast, By Indication 14.32.1. Cardiovascular Disorders 14.32.2. Oncology 14.32.3. Gastrointestinal Disorders 14.32.4. Musculoskeletal Disorders 14.32.5. Neurological Disorders 14.32.6. Nephrological Disorders 14.33. Rest of Asia Pacific Contrast Media Market Forecast, By Application 14.33.1. Nephrological disorders 14.33.2. Oncology 14.33.3. Cardiovascular disorders 14.33.4. Others 14.34. Asia Pacific Contrast Media Market Attractiveness Analysis 14.34.1. By Type 14.34.2. By Administration 14.34.3. By Indication 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Contrast Media Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Contrast Media Market Overview 15.3. Middle East & Africa Contrast Media Market Value Share Analysis, By Type 15.4. Middle East & Africa Contrast Media Market Forecast, By Type 15.4.1. Intravenous contrast materials 15.4.2. Iodine-based contrast media agents 15.4.3. Others 15.5. Middle East & Africa Contrast Media Market Value Share Analysis, By Administration 15.6. Middle East & Africa Contrast Media Market Forecast, By Administration 15.6.1. Injectable 15.6.2. Rectal 15.6.3. Oral 15.7. Middle East & Africa Contrast Media Market Value Share Analysis, By Indication 15.8. Middle East & Africa Contrast Media Market Forecast, By Indication 15.8.1. Cardiovascular Disorders 15.8.2. Oncology 15.8.3. Gastrointestinal Disorders 15.8.4. Musculoskeletal Disorders 15.8.5. Neurological Disorders 15.8.6. Nephrological Disorders 15.9. Middle East & Africa Contrast Media Market Value Share Analysis, By Application 15.10. Middle East & Africa Contrast Media Market Forecast, By Application 15.10.1. Nephrological disorders 15.10.2. Oncology 15.10.3. Cardiovascular disorders 15.10.4. Others 15.11. Middle East & Africa Contrast Media Market Value Share Analysis, by Country 15.12. Middle East & Africa Contrast Media Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Contrast Media Market Analysis, by Country 15.14. GCC Contrast Media Market Forecast, By Type 15.14.1. Intravenous contrast materials 15.14.2. Iodine-based contrast media agents 15.14.3. Others 15.15. GCC Contrast Media Market Forecast, By Administration 15.15.1. Injectable 15.15.2. Rectal 15.15.3. Oral 15.16. GCC Contrast Media Market Forecast, By Indication 15.16.1. Cardiovascular Disorders 15.16.2. Oncology 15.16.3. Gastrointestinal Disorders 15.16.4. Musculoskeletal Disorders 15.16.5. Neurological Disorders 15.16.6. Nephrological Disorders 15.17. GCC Contrast Media Market Forecast, By Application 15.17.1. Nephrological disorders 15.17.2. Oncology 15.17.3. Cardiovascular disorders 15.17.4. Others 15.18. South Africa Contrast Media Market Forecast, By Type 15.18.1. Intravenous contrast materials 15.18.2. Iodine-based contrast media agents 15.18.3. Others 15.19. South Africa Contrast Media Market Forecast, By Administration 15.19.1. Injectable 15.19.2. Rectal 15.19.3. Oral 15.20. South Africa Contrast Media Market Forecast, By Indication 15.20.1. Cardiovascular Disorders 15.20.2. Oncology 15.20.3. Gastrointestinal Disorders 15.20.4. Musculoskeletal Disorders 15.20.5. Neurological Disorders 15.20.6. Nephrological Disorders 15.21. South Africa Contrast Media Market Forecast, By Application 15.21.1. Nephrological disorders 15.21.2. Oncology 15.21.3. Cardiovascular disorders 15.21.4. Others 15.22. Rest of Middle East & Africa Contrast Media Market Forecast, By Type 15.22.1. Intravenous contrast materials 15.22.2. Iodine-based contrast media agents 15.22.3. Others 15.23. Rest of Middle East & Africa Contrast Media Market Forecast, By Administration 15.23.1. Injectable 15.23.2. Rectal 15.23.3. Oral 15.24. Rest of Middle East & Africa Contrast Media Market Forecast, By Indication 15.24.1. Cardiovascular Disorders 15.24.2. Oncology 15.24.3. Gastrointestinal Disorders 15.24.4. Musculoskeletal Disorders 15.24.5. Neurological Disorders 15.24.6. Nephrological Disorders 15.25. Rest of Middle East & Africa Contrast Media Market Forecast, By Application 15.25.1. Nephrological disorders 15.25.2. Oncology 15.25.3. Cardiovascular disorders 15.25.4. Others 15.26. Middle East & Africa Contrast Media Market Attractiveness Analysis 15.26.1. By Type 15.26.2. By Administration 15.26.3. By Indication 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Contrast Media Market Analysis 16.1. Key Findings 16.2. South America Contrast Media Market Overview 16.3. South America Contrast Media Market Value Share Analysis, By Type 16.4. South America Contrast Media Market Forecast, By Type 16.4.1. Intravenous contrast materials 16.4.2. Iodine-based contrast media agents 16.4.3. Others 16.5. South America Contrast Media Market Value Share Analysis, By Administration 16.6. South America Contrast Media Market Forecast, By Administration 16.6.1. Injectable 16.6.2. Rectal 16.6.3. Oral 16.7. South America Contrast Media Market Value Share Analysis, By Indication 16.8. South America Contrast Media Market Forecast, By Indication 16.8.1. Cardiovascular Disorders 16.8.2. Oncology 16.8.3. Gastrointestinal Disorders 16.8.4. Musculoskeletal Disorders 16.8.5. Neurological Disorders 16.8.6. Nephrological Disorders 16.9. South America Contrast Media Market Value Share Analysis, By Application 16.10. South America Contrast Media Market Forecast, By Application 16.10.1. Nephrological disorders 16.10.2. Oncology 16.10.3. Cardiovascular disorders 16.10.4. Others 16.11. South America Contrast Media Market Value Share Analysis, by Country 16.12. South America Contrast Media Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Contrast Media Market Analysis, by Country 16.14. Brazil Contrast Media Market Forecast, By Type 16.14.1. Intravenous contrast materials 16.14.2. Iodine-based contrast media agents 16.14.3. Others 16.15. Brazil Contrast Media Market Forecast, By Administration 16.15.1. Injectable 16.15.2. Rectal 16.15.3. Oral 16.16. Brazil Contrast Media Market Forecast, By Indication 16.16.1. Cardiovascular Disorders 16.16.2. Oncology 16.16.3. Gastrointestinal Disorders 16.16.4. Musculoskeletal Disorders 16.16.5. Neurological Disorders 16.16.6. Nephrological Disorders 16.17. Brazil Contrast Media Market Forecast, By Application 16.17.1. Nephrological disorders 16.17.2. Oncology 16.17.3. Cardiovascular disorders 16.17.4. Others 16.18. Mexico Contrast Media Market Forecast, By Type 16.18.1. Intravenous contrast materials 16.18.2. Iodine-based contrast media agents 16.18.3. Others 16.19. Mexico Contrast Media Market Forecast, By Administration 16.19.1. Injectable 16.19.2. Rectal 16.19.3. Oral 16.20. Mexico Contrast Media Market Forecast, By Indication 16.20.1. Cardiovascular Disorders 16.20.2. Oncology 16.20.3. Gastrointestinal Disorders 16.20.4. Musculoskeletal Disorders 16.20.5. Neurological Disorders 16.20.6. Nephrological Disorders 16.21. Mexico Contrast Media Market Forecast, By Application 16.21.1. Nephrological disorders 16.21.2. Oncology 16.21.3. Cardiovascular disorders 16.21.4. Others 16.22. Rest of South America Contrast Media Market Forecast, By Type 16.22.1. Intravenous contrast materials 16.22.2. Iodine-based contrast media agents 16.22.3. Others 16.23. Rest of South America Contrast Media Market Forecast, By Administration 16.23.1. Injectable 16.23.2. Rectal 16.23.3. Oral 16.24. Rest of South America Contrast Media Market Forecast, By Indication 16.24.1. Cardiovascular Disorders 16.24.2. Oncology 16.24.3. Gastrointestinal Disorders 16.24.4. Musculoskeletal Disorders 16.24.5. Neurological Disorders 16.24.6. Nephrological Disorders 16.25. Rest of South America Contrast Media Market Forecast, By Application 16.25.1. Nephrological disorders 16.25.2. Oncology 16.25.3. Cardiovascular disorders 16.25.4. Others 16.26. South America Contrast Media Market Attractiveness Analysis 16.26.1. By Type 16.26.2. By Administration 16.26.3. By Indication 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.4. M&A by Regions, Investment and Applications 17.2.5. M&A Key Players, Forward Integration and Backward 17.2.6. Integration 17.3. Company Profiles: Key Players 17.3.1. GE Healthcare 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. Bracco Imaging S.P.A. 17.3.3. Bayer AG 17.3.4. Guerbet Group 17.3.5. Lantheus Medical Imaging, Inc. 17.3.6. Daiichi Sankyo 17.3.7. Unijules Life Sciences 17.3.8. J.B. Chemicals and Pharmaceuticals Ltd. 17.3.9. Sanochemia 17.3.10. Magnus Health 17.3.11. Taejoon Pharm 17.3.12. Jodas Expoim 17.3.13. Nano Therapeutics Pvt. Ltd. 17.3.14. Kiran X-Ray 17.3.15. Interpharma Praha A.S. 17.3.16. Imax Diagnostic Imaging Limited 17.3.17. Yangtze River Pharmaceutical Group (YRPG) 17.3.18. Spago Nanomedical AB 17.3.19. Subhra Pharma Pvt. Ltd. 17.3.20. M. Biotech Limited 18. Primary Key Insights

About This Report

Report ID54969
Published DateMarch 2020
Contact Us
Call Now